Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are chronic diseases characterized by progressive or alternate impairment of neurological functions. Patients have to manage alternated periods in hospital with care at home, experiencing a constant uncertainty regarding the timing of the disease acute phases. Clinicians need tools able to support them in all the phases of the patient treatment and suggesting personalized therapeutic decisions.
AI is the key to successfully satisfy these needs to:

• better describe disease mechanisms;
• stratify patients according to their phenotype;
• predict disease progression;
• suggest interventions that can delay the progression of the disease.

Contacts:
Piero Fariselli
Project link: cordis.europa.eu